These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 35304322)
1. Iron ion-coordinated carrier-free supramolecular co-nanoassemblies of dual DNA topoisomerase-targeting inhibitors for tumor suppression. Guan J; Tan X; Jiao J; Lai S; Zhang H; Kan Q; He Z; Sun M; Sun J Acta Biomater; 2022 May; 144():121-131. PubMed ID: 35304322 [TBL] [Abstract][Full Text] [Related]
2. A targeted nanoplatform co-delivering chemotherapeutic and antiangiogenic drugs as a tool to reverse multidrug resistance in breast cancer. Tian F; Dahmani FZ; Qiao J; Ni J; Xiong H; Liu T; Zhou J; Yao J Acta Biomater; 2018 Jul; 75():398-412. PubMed ID: 29874597 [TBL] [Abstract][Full Text] [Related]
3. Methotrexate-Camptothecin Prodrug Nanoassemblies as a Versatile Nanoplatform for Biomodal Imaging-Guided Self-Active Targeted and Synergistic Chemotherapy. Li Y; Lin J; Ma J; Song L; Lin H; Tang B; Chen D; Su G; Ye S; Zhu X; Luo F; Hou Z ACS Appl Mater Interfaces; 2017 Oct; 9(40):34650-34665. PubMed ID: 28920426 [TBL] [Abstract][Full Text] [Related]
4. Tumor-Specific Endogenous Fe Fan Z; Jiang B; Zhu Q; Xiang S; Tu L; Yang Y; Zhao Q; Huang D; Han J; Su G; Ge D; Hou Z ACS Appl Mater Interfaces; 2020 Apr; 12(13):14884-14904. PubMed ID: 32167740 [TBL] [Abstract][Full Text] [Related]
5. Pure drug nano-assemblies: A facile carrier-free nanoplatform for efficient cancer therapy. Fu S; Li G; Zang W; Zhou X; Shi K; Zhai Y Acta Pharm Sin B; 2022 Jan; 12(1):92-106. PubMed ID: 35127374 [TBL] [Abstract][Full Text] [Related]
6. Core-matched nanoassemblies for targeted co-delivery of chemotherapy and photosensitizer to treat drug-resistant cancer. Jiang D; Xu M; Pei Y; Huang Y; Chen Y; Ma F; Lu H; Chen J Acta Biomater; 2019 Apr; 88():406-421. PubMed ID: 30763634 [TBL] [Abstract][Full Text] [Related]
7. Oxocrebanine: A Novel Dual Topoisomerase inhibitor, Suppressed the Proliferation of Breast Cancer Cells MCF-7 by Inducing DNA Damage and Mitotic Arrest. Yu L; Han S; Lang L; Song H; Zhang C; Dong L; Jia S; Zhang Y; Xiao D; Liu J; Xu Y; Zhang X Phytomedicine; 2021 Apr; 84():153504. PubMed ID: 33611211 [TBL] [Abstract][Full Text] [Related]
8. Carrier-free supramolecular nanoassemblies of pure LSD1 inhibitor for effective anti-tumor therapy. Li B; Zhang X; Li J Front Chem; 2022; 10():1012882. PubMed ID: 36247676 [TBL] [Abstract][Full Text] [Related]
9. Methoxy poly(ethylene glycol)-poly(lactide) nanoparticles encapsulating quercetin act as an effective anticancer agent by inducing apoptosis in breast cancer. Sharma G; Park J; Sharma AR; Jung JS; Kim H; Chakraborty C; Song DK; Lee SS; Nam JS Pharm Res; 2015 Feb; 32(2):723-35. PubMed ID: 25186442 [TBL] [Abstract][Full Text] [Related]
10. Gold nanoparticles-conjugated quercetin induces apoptosis via inhibition of EGFR/PI3K/Akt-mediated pathway in breast cancer cell lines (MCF-7 and MDA-MB-231). Balakrishnan S; Mukherjee S; Das S; Bhat FA; Raja Singh P; Patra CR; Arunakaran J Cell Biochem Funct; 2017 Jun; 35(4):217-231. PubMed ID: 28498520 [TBL] [Abstract][Full Text] [Related]
11. Gold nanoparticle-conjugated quercetin inhibits epithelial-mesenchymal transition, angiogenesis and invasiveness via EGFR/VEGFR-2-mediated pathway in breast cancer. Balakrishnan S; Bhat FA; Raja Singh P; Mukherjee S; Elumalai P; Das S; Patra CR; Arunakaran J Cell Prolif; 2016 Dec; 49(6):678-697. PubMed ID: 27641938 [TBL] [Abstract][Full Text] [Related]
12. Polyethyleneimine- -Tocopherol Hydrogen Succinate/Hyaluronic Acid-Quercetin (PEI-TOS/HA-QU) Core-Shell Micelles Delivering Paclitaxel for Combinatorial Treatment of MDR Breast Cancer. Qian J; Liu S; Yang T; Xiao Y; Sun J; Zhao J; Zhang Z; Xie Y J Biomed Nanotechnol; 2021 Mar; 17(3):382-398. PubMed ID: 33875073 [TBL] [Abstract][Full Text] [Related]
13. Multifunctional low-temperature photothermal nanodrug with in vivo clearance, ROS-Scavenging and anti-inflammatory abilities. Yang GG; Zhou DJ; Pan ZY; Yang J; Zhang DY; Cao Q; Ji LN; Mao ZW Biomaterials; 2019 Sep; 216():119280. PubMed ID: 31228705 [TBL] [Abstract][Full Text] [Related]
14. Construction of quercetin-fucoidan nanoparticles and their application in cancer chemo-immunotherapy treatment. Lin Z; Liu Y; Gong X; Nie F; Xu J; Guo Y Int J Biol Macromol; 2024 Jan; 256(Pt 1):128057. PubMed ID: 37956805 [TBL] [Abstract][Full Text] [Related]
15. Synergistic inhibition of migration and invasion of breast cancer cells by dual docetaxel/quercetin-loaded nanoparticles via Akt/MMP-9 pathway. Li J; Zhang J; Wang Y; Liang X; Wusiman Z; Yin Y; Shen Q Int J Pharm; 2017 May; 523(1):300-309. PubMed ID: 28336457 [TBL] [Abstract][Full Text] [Related]
16. "Watson-Crick G[triple bond, length as m-dash]C"-inspired supramolecular nanodrug of methotrexate and 5-fluorouracil for tumor microenvironment-activatable self-recognizing synergistic chemotherapy. Chen M; Chen S; Zhu F; Wang F; Tian H; Fan Z; Ke S; Hou Z; Li Y J Mater Chem B; 2020 May; 8(17):3829-3841. PubMed ID: 32232285 [TBL] [Abstract][Full Text] [Related]
17. Iron chelators with topoisomerase-inhibitory activity and their anticancer applications. Rao VA Antioxid Redox Signal; 2013 Mar; 18(8):930-55. PubMed ID: 22900902 [TBL] [Abstract][Full Text] [Related]
18. Quercetin exerts synergetic anti-cancer activity with 10-hydroxy camptothecin. Tang Q; Ji F; Wang J; Guo L; Li Y; Bao Y Eur J Pharm Sci; 2017 Nov; 109():223-232. PubMed ID: 28822757 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of growth and lung metastasis of breast cancer by tumor-homing triple-bioresponsive nanotherapeutics. Zhang X; Huang Y; Song H; Canup BSB; Gou S; She Z; Dai F; Ke B; Xiao B J Control Release; 2020 Dec; 328():454-469. PubMed ID: 32890553 [TBL] [Abstract][Full Text] [Related]
20. Rapid pH-responsive self-disintegrating nanoassemblies balance tumor accumulation and penetration for enhanced anti-breast cancer therapy. Li J; Wang Y; Xu C; Yu Q; Wang X; Xie H; Tian L; Qiu Y; Guo R; Lu Z; Li M; He Q Acta Biomater; 2021 Oct; 134():546-558. PubMed ID: 33882357 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]